​

Funding Round

Series B - Click Therapeutics

Series B - Click Therapeutics

Investment Firm

Overview

Click Therapeutics delivers safe and effective digital treatments to patients in need.

Announced Date

Oct 22, 2021

Closed on Date

Oct 22, 2021

Funding Type

Series B

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners is a debt and early_stage_venture and late_stage_venture and venture firm.

Accelmed

Accelmed

Accelmed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

8

Investor Name
Participant InvestorK2 HealthVentures
Participant InvestorRevelation Partners
Participant InvestorAccelmed
Participant InvestorSanofi Ventures
Participant InvestorH.I.G. BioHealth Partners

Round Details and Background

Click Therapeutics raised $52000000 on 2021-10-22 in Series B

Click Therapeutics delivers safe and effective digital treatments to patients in need.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 19, 2016
Convertible Note - Click Therapeutics
-950.0K
Apr 15, 2012
Seed Round - Click Therapeutics
3-200.0K
Oct 01, 2014
Convertible Note - Click Therapeutics
-1.7M
Aug 06, 2015
Convertible Note - Click Therapeutics
1-1.8M

Recent Activity

There is no recent news or activity for this profile.